AALL1732
OPEN TO ACCRUAL
Phase 3 Inotuzumab Ozogamicin for Newly Dx HR B ALL plus MPAL and Disseminated B LLy
AALL2131
OPEN TO ACCRUAL
Pilot Study of Chemo and TKIs with Blinatumomab in New Dx Ph+ or Ph-like B-ALL
AAML1831
OPEN TO ACCRUAL
Phase 3 Study for AML Comparing Standard Therapy to CPX-351 plus Gilteritinib for FLT3
ALTE2131
OPEN TO ACCRUAL
Ph3 Triptorelin and Protection of Ovarian Reserve in AYA with Cancer
ALTE2321
OPEN TO ACCRUAL
Walking Juntos: A Phase 2b Study of Social Media Physical Activity Intervention Among AYA Survivors
APAL2020SC
OPEN TO ACCRUAL
PedAL Screening Trial - Developing new therapies for Relapsed Leukemias.
APEC14B1
OPEN TO ACCRUAL
Project: Every Child A Registry, Eligibility Screening, Biology and Outcome Study
UW23111
OPEN TO ACCRUAL
POETIC PARPAML, Phase 1 Relapsed Pediatric AML using Talazoparib
UW25071
OPEN TO ACCRUAL
Pediatric Oncology Clinicians' Experiences Collecting and Managing Multi-Informant Symptom Data
UW25098
OPEN TO ACCRUAL
Exploring Adolescent Patient Experiences in Receiving Blinatumomab